LADR – LABORATORY GROUP DR. KRAMER & COLLEAGUES acquired by SONIC HEALTHCARE
Context
Sonic Healthcare has signed binding agreements to acquire the LADR Laboratory Group, marking a substantial expansion of its German and European diagnostic footprint. The transaction was structured on a cash and debt-free basis, with a total consideration satisfied through a mix of Sonic ordinary shares (up to 222 million euros) and cash funded from existing facilities. The strategic rationale centers on the strong cultural and operational alignment between the two organizations, with significant synergy potential identified in procurement, laboratory overlaps, logistics, and equipment maintenance. The deal also includes an inherited put/call structure for a separate German laboratory business, expected to be fully consolidated by 2027. Following the acquisition, the target's senior leadership, including the CEO and Medical Director, will remain with the group to lead the integration collaboratively with the acquirer’s German division.
LADR – LABORATORY GROUP DR. KRAMER & COLLEAGUES, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.5x).
-> Deep-dive in Healthcare & Pharma market trends
Target
LADR is one of the top five medical laboratory groups in Germany, providing high-quality diagnostic testing services through a national network of stand-alone and hospital-based laboratories. Founded in 1945 and managed by the third generation of the Kramer family, the group's business model is predominantly focused on medical laboratory revenue (80% of total), supplemented by medical supplies trading, logistical services, and a specialized clinical services division focused on women’s health. The group maintains a significant international footprint, including "badaj.to," the fourth largest laboratory group in Poland, and a joint-venture interest in Finland. Operating with over 2,800 full-time staff, LADR leverages a centralized laboratory hub in Geesthacht to provide comprehensive diagnostic solutions across the German healthcare landscape, emphasizing medical leadership and high-quality clinical outcomes.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 05/2025 | FONDATION SANTE SERVICE | CLARIANE HAD (HOME HOSPITALIZATION SERVICES) | FRANCE | Outpatient Care |
| 04/2025 | EUROFINS SCIENTIFIC | SYNLAB SPAIN | SPAIN | Labs (Biology) |
| 12/2024 | CAPZA | IMDEV | FRANCE | Radiology |
| 11/2024 | WELLTOWER | CARE UK | UNITED KINGDOM | Nursing Homes |
| 11/2024 | GROUPE IMAGERIE CARDINET | RADIOLOGIE PARIS OUEST | FRANCE | Radiology |
| 10/2024 | MONTEFIORE INVESTMENT | DEMENEGO | ITALY | Ophthalmology |
| 10/2024 | ARDIAN | VISTA VISION | ITALY | Ophthalmology |
| 10/2024 | QUALIUM | IMPC (IMAGERIE MEDICALE PARIS CENTRE) | FRANCE | Radiology |
| 08/2024 | ORLANDO HEALTH | BROOKWOOD BAPTIST HEALTH SERVICES | UNITED STATES | Clinics / Hospitals |
| 06/2024 | INTEGRAL DIAGNOSTICS LIMITED | CAPITOL HEALTH LIMITED | AUSTRALIA | Radiology |
REFERENCES
Valuation range: EV 300M - 700M EUR
Revenue range: 250M - 500M EUR
EBITDA range: 50M - 100M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of LADR – LABORATORY GROUP DR. KRAMER & COLLEAGUES by SONIC HEALTHCARE are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.